|
?:authorAffiliation
|
-
[\'National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.\', \'School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.\', \'Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'MassGenics, Duluth, Georgia, USA.\', \'School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.\', \'School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.\', \'Department of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa.\', \'South African Medical Research Council: Vaccines and Infectious Diseases Analytical Research Unit (VIDA), Faculty of Health Science Johannesburg, University of the Witwatersrand, Johannesburg, South Africa.\', \'Department of Science/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Science Johannesburg, University of the Witwatersrand, Johannesburg, South Africa.\', \'Dept of Paediatrics and Child Health, Red Cross Children\'s Hospital, and SA-MRC Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}